Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

BACKGROUND: Primary retroperitoneal lymph node dissection (RPLND) ultimately lost its role as the standard management of clinical stage (CS) 1 nonseminomatous (NS) testicular germ cell tumours (GCTs) in Europe when the European Germ Cell Cancer Consensus Group released their recommendations in 2008....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Urol
Päätekijät: Dieckmann, K.-P., Anheuser, P., Kulejewski, M., Gehrckens, R., Feyerabend, B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204050/
https://ncbi.nlm.nih.gov/pubmed/30367648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0412-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia